STEALTHKINE
Live / Applied — Fifth extension granted (statement of use) (as of 08 Dec 2025)
What this means for you
Not registered yet, but its 01 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97439030
- Mark type
- Stylized text
- Filed
- 01 Jun 2022
- Published for opposition
- 11 Apr 2023
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 042 — Scientific and technological services: Genetic engineering services, namely, the production of genetically-engineered antibodies for others
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 08 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Dec 2025 — SOU EXTENSION 5 GRANTED
- 06 Dec 2025 — SOU EXTENSION 5 FILED
- 06 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 May 2025 — SOU EXTENSION 4 GRANTED
- 10 May 2025 — SOU EXTENSION 4 FILED
- 09 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2025 — SOU EXTENSION 3 GRANTED
- 16 Nov 2024 — SOU EXTENSION 3 FILED
- 31 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL